Use Of A Glucocorticoid Composition For The Treatment Of Severe And Uncontrolled Asthma

Patent No. EP2393477 (titled "Use Of A Glucocorticoid Composition For The Treatment Of Severe And Uncontrolled Asthma") was filed by Activaero on Feb 3, 2010. The application was issued on Dec 27, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA UKSep 26, 2018GILLARD
TEVA PHARMACEUTICALSSep 26, 2018ELKINGTON AND FIFE
TEVA PHARMACEUTICALSSep 26, 2018ELKINGTON & FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2393477

ACTIVAERO
Application Number
EP10705986A
Filing Date
Feb 3, 2010
Status
Revoked
Aug 14, 2020
Publication Date
Dec 27, 2017